Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions.

Created on 31 Jul 2026

Authors

Takefumi Onodera, Shuichi Sakamoto, Shunichi Ohba, Manabu Kawada, Isao Momose

Published in

Oncogene. Jul 30, 2026. Epub Jul 30, 2026.

Abstract

Pancreatic tumors frequently develop in nutrient-poor microenvironments due to impaired perfusion, forcing cancer cells to engage in metabolic adaptation for survival. This study identified the upregulation of transketolase-like 1 (TKTL1) as a nutrient-stress-responsive factor associated with metabolic adaptation of pancreatic cancer cells under amino-acid starvation, particularly glutamine scarcity. In particular, we found that TKTL1 induction was specifically observed in cancer cells and not in normal pancreatic ductal cells. Functional assays showed that TKTL1 overexpression increased proliferative capacity and tumor growth, whereas its knockdown attenuated these phenotypes and reduced cancer cell fitness under nutrient stress. Although TKTL1 exhibits weak intrinsic enzymatic activity, our data support a functional association with transketolase (TKT), accompanied by increased total transketolase activity. Protein-protein interaction assays further indicated that TKTL1 binds to TKT more prominently under nutrient deprivation than under nutrient-rich conditions. Furthermore, transcriptional analyses and NF-κB inhibition experiments suggest that TKTL1 upregulation is partially regulated by the NF-κB/p50 axis. Together, these findings are consistent with a model in which TKTL1 contributes to metabolic adaptation and stress tolerance in nutrient-deprived pancreatic cancer cells, in part through interaction with TKT, and suggest that the TKTL1 axis may represent a context-dependent therapeutic target in nutrient-limited tumors.

PMID:
42533116
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement